- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Article
This Week in Aesthetics: August 2-6
Author(s):
This week in aesthetics, we highlight plastic surgery resident burnout, ritlecitinib for alopecia areata, and more.
This week in aesthetics, we take a look behind the scenes at the Aesthetics Biomedical's "Perspectives: The Evolution of Aesthetics" symposium, AbbVie and Calico Life Sciences extend their collaboration for the research, development, and commercialization of new treatments focused on age and age-related diseases, Shino Bay Aguilera, DO, reflects on his ABM keynote address highlighting diversity and wellness in aesthetic medicine, a recent study investigates the wellness training plastic surgery residents receive to prevent burnout and improve patient outcomes, ritlecitinib achieves its primary endpoint in treating alopecia areata, and we take a deep dive into The Box By Dr. Ava’s summer edition.
Behind the Scenes at the ABM Perspectives Symposium
Take a look behind the scenes at the Aesthetics Biomedical's "Perspectives: The Evolution of Aesthetics" symposium held July 24th in Orlando, Florida.
AbbVie and Calico Extend Age-Related Disease Collaboration
AbbVie and Calico Life Sciences have extended their collaboration for the research, development, and commercialization of new treatments focused on age and age-related diseases.
Diversity and Wellness with Shino Bay Aguilera, DO
Shino Bay Aguilera, DO, reflects on his keynote address highlighting diversity and wellness in aesthetic medicine at Aesthetics Biomedical’s “Perspectives: The Evolution of Aesthetics” symposium.
Are Aesthetic Residents Adequately Trained to Prevent Burnout?
A recent study investigates the wellness training plastic surgery residents receive to prevent burnout and improve patient outcomes.
Ritlecitinib Delivers Topline Results in Alopecia Areata Study
Ritlecitinib, an investigational covalent kinase inhibitor, achieved its primary endpoint and demonstrated statistically significant efficacy compared to placebo in treating alopecia areata.
Inside The Box By Dr. Ava: Summer Edition
Aesthetic Authority™ takes a deep dive into The Box By Dr. Ava’s summer edition, including not only skin care products, but hair care, and a resource center to boot.
